Glanbia PLC Full‑Year Guidance Upgrade
Glanbia PLC, the Irish nutrition group, announced on 6 August 2026 that it is raising its full‑year earnings outlook after delivering strong first‑half results. For the six months ended 4 July, revenue increased 7.0 % on a constant‑currency basis to US$2.08 billion and EBITDA rose 14.1 % to US$275.4 million. Adjusted earnings per share for the period climbed 30 % to 81.24 U.S. cents.
The company now expects adjusted earnings per share to grow between 17 % and 20 % in constant currency for the full year, up from its prior guidance of 7 %‑11 % at the upper end of the range.
Division‑level performance showed a 16.9 % like‑for‑like revenue increase in Performance Nutrition, driven by strong gains at the Optimum Nutrition brand, while Health & Nutrition recorded 12.0 % like‑for‑like revenue growth. Dairy Nutrition contributed a near‑28 % rise in EBITDA as demand for higher‑value protein solutions remained robust.
Chief Executive Officer Hugh McGuire noted that demand stayed strong across all three divisions despite elevated whey input costs and an uncertain geopolitical backdrop.
In addition to the earnings upgrade, Glanbia increased its annual cost‑savings target to US$70 million by fiscal 2027, raised its interim dividend by 10 %, and returned €100 million to shareholders through share buybacks.